Based on the latest analysis from Future Market Insights, the global pharmaceutical lactose market is anticipated to reach ...
This article from Molecular Devices explores how cell painting can be used in a 3D breast cancer spheroid model for ...
In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $6.67, indicating a -1.91% shift from the previous trading day.
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $460, moving -1.06% from the previous trading session.
Hans-Georg Feldmeier, CEO der Dermapharm, verlangt bessere Rahmenbedingungen für Arzneimittelhersteller in Deutschland. Der Biontech-Zulieferer aus Grünwald bei München warnt vor Lieferengpässen und A ...